This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Janet Woodcock, M.D., Acting Commissioner

Event Date: 10/04/2021
Location: Virtual
Subject: Longwood Healthcare Leaders Meeting
FDA Participant/Group: DAYLE CRISTINZIO;
Non FDA Participant/Group: Government, industry, academia, and other invited guests

Event Date: 10/04/2021
Location: Virtual
Subject: Global Summit on Regulatory Science; Speaker: Opening Remarks
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, industry, academia, media, and other registered guests

Event Date: 10/06/2021
Location: Virtual
Subject: Trial Updates and Protocols
FDA Participant/Group: PETER STEIN;
Non FDA Participant/Group: Parties involved in Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)

Event Date: 10/06/2021
Location: Virtual
Subject: National Food Policy Conference
FDA Participant/Group: SUSAN MAYNE; KIMBERLY DIFONZO;
Non FDA Participant/Group: Government, industry, academia, media, and other registered guests

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 10/04/2021
Location: Virtual
Subject: Global Summit on Regulatory Science; Keynote Speaker: New Era of Smarter Food Safety Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Scientists from government, industry, and the academic research communities

Event Date: 10/05/2021
Location: Virtual
Subject: Food Safety Issues of Mutual Interest Sustainable Food Policy Alliance
FDA Participant/Group: CAITLIN BOON; SUSAN MAYNE; KARI BARRETT;
Non FDA Participant/Group: Several members and staff of the Sustainable Food Policy Alliance

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

Event Date: 10/05/2021
Location: Queens, NY
Subject: John F. Kennedy Airport International Mail Facility Tour
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representative David Trone (D-MD) and staff, representatives from the Office of National Drug Control Policy (ONDCP) / Commission on Combating Synthetic Opioid Trafficking, Customs and Border Patrol (CBP), United States Postal Inspection Service (USPIS), and Homeland Security Investigations (HSI)

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 10/04/2021
Location: Virtual
Subject: Meeting of the Directors of the National Cancer Institute (NCI) Designated Cancer Centers
FDA Participant/Group: N/A
Non FDA Participant/Group: Leadership of Designated Cancer Centers

Event Date: 10/05/2021
Location: Virtual
Subject: National Academies of Sciences, Engineering and Medicine (NASEM) Workshop; Panelist: FDA Emergency Use Authoriazation (EUA)
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from industry, academia, and other stakeholders

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 10/05/2021
Location: Virtual
Subject: 24th Annual Cowen Therapeutics Conference; Panelist: FDA Roundtable
FDA Participant/Group: RICHARD PAZDUR;
Non FDA Participant/Group: Attendees of the Cowen Therapeutics Conference

Event Date: 10/05/2021
Location: Virtual
Subject: COVID-19 Vaccine Education and Equity Project Partner Townhall; Speaker: Addressing Questions About COVID-19 Boosters and Vaccines
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the COVID-19 Vaccine Education and Equity Project Partner Townhall

Event Date: 10/06/2021
Location: Virtual
Subject: Keynote Speaker: Informing the Future from COVID-19 Lessons Learned
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard Conference; Advancing International Pediatric Clinical Research, Part One

Event Date: 10/08/2021
Location: Virtual
Subject: Speaker and Panelist: Innovation in COVID-19 Management and Long Hauler Patients
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the New York American College of Physicians Annual Scientific Meeting

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 10/06/2021
Location: Virtual
Subject: Patient Engagement Advisory Committee Meeting; Speaker: Medical Device Recall Communication
FDA Participant/Group: LETISE WILLIAMS; ERIN KEITH; ANGELA CALMAN;
Non FDA Participant/Group: Patients, caregivers, and representatives of patient organizations

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

Event Date: 10/04/2021
Location: Virtual
Subject: 2021 Global Summit on Regulatory Science; Speaker: Opening Remarks
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, and government

Official Name: Mark Raza, J.D., Acting Chief Counsel

No Significant Event